CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GuiZhou YiBai Pharmaceutical Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GuiZhou YiBai Pharmaceutical Co., Ltd.
No. 220-1 Baiyun Avenue, Yunyan District
Phone: +86 85184705177p:+86 85184705177 GUIYANG, GUZ  550008  China Ticker: 600594600594
Business Summary
Guizhou Yibai Pharmaceutical Co Ltd is a China-based company principally engaged in pharmaceutical industry, medical services, and big health industry businesses. The pharmaceutical industry business is mainly engaged in the research and development, production and sales of chemical drugs, traditional Chinese medicines, biological drugs and other drugs. The medical service business is mainly engaged in the operation and management of comprehensive hospitals, tumor specialty hospitals, and tumor radiotherapy centers. The big health industry business is mainly engaged in the development, research, production and sales of big health products featuring Miao medicine. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8062 General medical and surgical hospitals
8069 Specialty hospitals, except psychiatric

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Qi L.Dou 53 12/31/2014 1/1/1995
Vice Chairman of the Board, General Manager YaqiDou 40 5/16/2024 9/17/2019
Finance Director XiantiZeng 49 9/7/2024 9/7/2024
12 additional Officers and Directors records available in full report.

Business Names
Business Name
600594
Guizhou Yibai Pharmaceutical Co., Ltd.

General Information
Number of Employees: 5,509 (As of 12/31/2023)
Outstanding Shares: 791,927,400 (As of 9/30/2024)
Shareholders: 53,370
Stock Exchange: SHA
Fax Number: +86 85184719910


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025